Pharmafile Logo
Pharmafocus logo
Advanced Search
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

November 13, 2020
Medical Communications

The top ten news stories this week focus on COVID-19 vaccines, with clinical trial participants who received the Pfizer/BioNTech coronavirus …

News
1200px-astrazeneca_hq_in_cambridge_uk

AstraZeneca’s Calquence fails to improve survival rates in coronavirus patients

November 12, 2020
Business Services AZ, AstraZeneca, Calquence

AstraZeneca’s Calquence has failed to improve survival rates and prevent lung failure in patients hospitalised with COVID-19.  Calquence (acalabrutinib) is …

News

NICE recommends Sanofi’s Cablivi for ultra-rare acute thrombotic thrombocytopenic purpura

November 12, 2020
Sales and Marketing NHS, NICE, Sanofi, pharma

Sanofi’s Cablivi (caplacizumab) has received recommendation from NICE for routine NHS use in England and Wales for the treatment of …

News
steven_ferdman-getty_images

Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data

November 12, 2020
Sales and Marketing COVID-19, Pfizer, Vaccine, pharma

With the news that Pfizer and BioNTech’s COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it …

News
depressed_4649749639

COVID-19 increases the risk of developing psychiatric disorders, new study says

November 12, 2020
Business Services

People who are infected with COVID-19 are at higher risk of developing depression, insomnia and anxiety for the first time, …

News
flu_vaccination_grippe_5115654021

Pfizer/BioNTech vaccine side effects feel like a “severe hangover”

November 12, 2020
Business Services COVID, Vaccine, coronavirus

Clinical trial participants receiving the Pfizer/BioNTech coronavirus vaccine have said it created side effects that felt similar to a “severe …

News
reuters_-_tatyana_makeyeva

First interim Phase 3 data shows promise for Russia’s Sputnik V COVID-19 vaccine

November 11, 2020
Research and Development COVID-19, Russia, Sputnik V, Vaccine

The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center …

News
1200px-vaccine_image_1

Head of UK vaccine taskforce grilled over government investment into her private equity firm

November 11, 2020
Research and Development COVID, UK COVID, coronavirus

Kate Bingham, the Head of the British Government’s vaccine taskforce, is facing further questions over a conflict of interest as …

News
512px-curevac_in_tubingen_02

CureVac’s COVID-19 vaccine generates immune responses at Phase 1

November 11, 2020
Research and Development COVID-19, CureVac, pharma

German biopharma firm CureVac has unveiled interim analysis data from a Phase1 study of its messenger RNA (mRNA) COVID-19 vaccine, CVnCoV, …

News
gym_wiki

Hotels, gyms and restaurants carry highest COVID-19 spread risk, new study says

November 11, 2020
Research and Development COVID, coronavirus

Reopening hotels, gyms and restaurants carries the highest risk of spreading coronavirus, according to a new study. 

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 11, 2020
Research and Development

The COVID-19 news this week focuses on vaccines, with AstraZeneca committing to an agreement to deliver 22 million doses of …

News
vaccination-1215279_960_720

Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis

November 10, 2020
Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …

News
nice_reception_2

NICE recommends venetoclax combo, a non-chemo option for untreated chronic lymphocytic leukaemia

November 10, 2020
Manufacturing and Production, Sales and Marketing AbbVie, NHS, NICE, UK, leukaemia, venetoclax

NICE has recommended venetoclax in combination with obinutuzumab under final draft guidance for the first-line treatment of untreated chronic lymphocytic …

News
stethoscope_and_background_doctor

Scottish Medicines Consortium greenlights Nubeqa for prostate cancer

November 10, 2020
Manufacturing and Production, Sales and Marketing

The Scottish Medicines Consortium has approved Nubeqa for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC) who are …

News
unnamed_1

FDA grants Emergency Use Authorization to Eli Lilly’s antibody drug to treat COVID-19

November 10, 2020
Manufacturing and Production

The FDA has granted Emergency Use Authorization (EUA) to Eli Lilly’s antibody drug bamlanivimab for the treatment of COVID-19 patients …

News
flu_vaccination_grippe_5115654021

Sinovac COVID-19 trial suspended in Brazil due to severe adverse event

November 10, 2020
Manufacturing and Production Brazil, COVID, COVID Vaccine, coronavirus

Brazil’s health regulator Anvisa has suspended a clinical trial for China’s Sinovac coronavirus vaccine due to the occurrence of a …

News
astrazeneca_sign_sky

Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni

November 9, 2020
Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …

News
shutter

AstraZeneca’s Brilinta combo reduces rate of disabling stroke or death in stroke patients, according to Phase 3 data

November 9, 2020
Research and Development, Sales and Marketing AstraZeneca, Brilinta, pharma

AstraZeneca has unveiled new Phase 3 data for Brilinta (ticagrelor) as a treatment for patients who have suffered an acute …

News
1200px-vaccine_image_1

Head of UK’s COVID-19 vaccine taskforce faces questions over biotech fund

November 9, 2020
Sales and Marketing COVID, COVID-19, vaccines

Kate Bingham, the head of the British Government’s vaccine taskforce, faces scrutiny after it was revealed her venture capital firm …

News
fda_white_oak_building_web_0

FDA approves Nightware app on Apple Watch to treat sleep disturbances

November 9, 2020
Sales and Marketing

The FDA has authorised the marketing of Nightware, a digital therapeutic application for the Apple Watch, in treating sleep disturbances.  …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025